The Challenges of Pediatric Drug Development

por Rose, Klaus
Publicado 2019

A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials

por Rose, Klaus, Kummer, Hans
Publicado 2015

The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia

por Rose, Klaus, Walson, Philip D
Publicado 2015

Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency

por Rose, Klaus, Spigarelli, Michael G.
Publicado 2015

Are Regulatory Age Limits in Pediatric Melanoma Justified?

por Rose, Klaus, Walson, Philip D.
Publicado 2019

Pediatric Melanoma and Drug Development

por Rose, Klaus, Grant-Kels, Jane M.
Publicado 2018

Pediatric melanoma—The whole (conflicts of interest) story()

por Rose, Klaus, Grant-Kels, Jane M.
Publicado 2018

Rational Use of Medicine in Children—The Conflict of Interests Story. A Review

por Rose, Klaus, Neubauer, David, Grant-Kels, Jane M.
Publicado 2019

Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia

por Rose, Klaus, Neubauer, David, Grant-Kels, Jane M.
Publicado 2019

Too Many Avoidable Suicides Occur Worldwide in Young Patients

por Rose, Klaus, Neubauer, David, Grant-Kels, Jane M.
Publicado 2019

Letter to the Editor: Delayed Presentation of Non-COVID-19 Patients During the COVID-19 Pandemic Is Not Limited to Children

por Rose, Klaus, Tanjinatus, Oishi, Grant-Kels, Jane, Ettienne, Earl B., Striano, Pasquale
Publicado 2021

COVID-19 and Treatment and Immunization of Children—The Time to Redefine Pediatric Age Groups is Here

por Rose, Klaus, Grant-Kels, Jane M., Ettienne, Earl B., Tanjinatus, Oishi, Striano, Pasquale, Neubauer, David
Publicado 2021